ESSA Pharma Inc. - Common Shares, no par value per share (EPIX)

Historical Holders from Q2 2018 to Q3 2025

Symbol
EPIX
Type / Class
Equity / Common Shares, no par value per share
Shares outstanding
47,601,550
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
22,521,153
Holdings value
$4,301,583
% of all portfolios
0%
Number of holders
32
Number of buys
16
Number of sells
-19
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 9.8% +94% $7,415,444 +$3,570,000 4,362,026 +92.8% SOLEUS CAPITAL MASTER FUND, L.P. 17 Jul 2025
BML Investment Partners, L.P. 9.5% +1.1% $7,598,783 +$68,981 4,221,546 +0.92% BML Investment Partners, L.P. 24 Apr 2025
MORGAN STANLEY 4% $456,975 1,904,062 Morgan Stanley 30 Sep 2025
RTW INVESTMENTS, LP 2.5% $2,003,404 1,113,002 RTW Investments, LP 31 Dec 2024

Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 22,521,153 $4,301,583 -$19,774,211 $0.191 32
2025 Q2 30,970,782 $52,650,184 -$1,127,767 $1.7 35
2025 Q1 31,681,355 $50,056,171 -$2,246,323 $1.58 35
2024 Q4 32,829,217 $58,763,166 -$67,554,468 $1.79 44
2024 Q3 35,103,052 $212,724,662 +$269,717 $6.06 32
2024 Q2 35,208,390 $185,094,881 +$787,443 $5.26 31
2024 Q1 35,037,057 $297,463,581 +$2,481,095 $8.49 33
2023 Q4 34,772,388 $229,436,154 +$13,901,733 $6.6 31
2023 Q3 33,469,182 $103,416,891 +$681,859 $3.09 36
2023 Q2 33,249,423 $89,773,501 +$345,204 $2.7 38
2023 Q1 33,092,147 $98,277,629 +$349,180 $2.97 36
2022 Q4 33,368,813 $84,091,085 +$2,320,053 $2.52 43
2022 Q3 33,417,334 $60,814,684 -$15,060,697 $1.82 49
2022 Q2 37,773,975 $118,994,687 -$275,773 $3.15 55
2022 Q1 37,197,195 $229,891,130 -$37,768,183 $6.18 66
2021 Q4 37,334,475 $530,072,278 +$7,512,573 $14.2 58
2021 Q3 37,173,724 $297,437,064 -$67,533,896 $8 74
2021 Q2 34,155,853 $975,990,399 +$94,781,085 $28.57 78
2021 Q1 30,834,019 $895,742,171 +$247,196,452 $29.05 68
2020 Q4 23,117,706 $274,324,124 +$29,029,638 $11.93 38
2020 Q3 20,317,336 $139,156,228 +$43,178,452 $6.9 33
2020 Q2 14,061,425 $86,521,104 -$1,180,827 $6.2 19
2020 Q1 14,249,424 $56,595,712 +$1,185,503 $4 15
2019 Q4 13,929,616 $76,086,979 +$219,855 $5.5 18
2019 Q3 12,232,081 $40,883,600 +$22,644,720 $3.37 12
2019 Q2 5,481,234 $13,087,000 +$3,840,427 $2.45 7
2019 Q1 3,828,813 $13,059,000 +$208 $3.4 7
2018 Q4 3,828,750 $8,040,000 +$3,510,215 $2.1 7
2018 Q3 3,825,113 $6,525,006 +$3,200,797 $3 7
2018 Q2 2,749,482 $10,410,000 +$10,410,000 $3.78 6